Open IPO

Hannah Joseph Hospital IPO Closes Today; Subscribed 0.59x So Far with Focus on Oncology Expansion

Hannah Joseph Hospital IPO Closes Today; Subscribed 0.59x So Far with Focus on Oncology Expansion

The bidding window for the Hannah Joseph Hospital IPO officially closes today, January 27, 2026, at 5:00 PM IST. As of the final morning, the issue has been subscribed approximately 0.59 times overall. The institutional category (QIB) leads with roughly 0.63x subscription, followed by Non-Institutional Investors (NII) at 1.05x, while the retail segment stands at 0.22x.

Operating as a 150-bed tertiary care facility in Tamil Nadu, the hospital is raising funds primarily to establish a new Radiation Oncology Centre. This move is expected to transform the facility into a comprehensive cancer care hub. Financially, the company has shown a positive trend, reporting a Profit After Tax (PAT) of ₹5.12 crore for the first half of FY26 (H1 FY26), compared to ₹7.21 crore for the entire previous fiscal year.

The Grey Market Premium (GMP) as of today, January 27, continues to hold at ₹0, indicating a neutral market sentiment with shares expected to list at or near the issue price of ₹70.

Final Day IPO Status & Timetable

Feature Details
Price Band ₹67 – ₹70 per share
Today's Status Closing Day (Last chance to bid)
Overall Subscription ~0.59x (as of 10:00 AM)
Lot Size 2,000 Shares (Min. Investment ₹2,80,000 for Retail*)
Allotment Date January 28, 2026 (Tomorrow)
Tentative Listing January 30, 2026 (Friday)

*Note: Retail investors must apply for a minimum of 2 lots (4,000 shares) for this issue.

Important Note for Investors

Project Pipeline: Over 80% of the funds (₹34.98 crore) are allocated for the new Oncology unit. Successful execution here is critical for the stock's future valuation, as oncology typically offers higher margins than general trauma care.

Low Occupancy Risk: The hospital’s occupancy rate currently stands at approximately 38%. While there is massive "headroom" to grow revenue without adding beds, a lack of patient volume growth could strain return on capital.

Geographical Niche: The hospital is a dominant referral center in South Tamil Nadu for complex neurosurgery. This regional strength is a "moat," but also a risk if local competition intensifies.

High Ticket Size: Being an SME IPO with a minimum application of ₹2.8 lakh, the barrier to entry is higher for small retail investors, which explains the slower retail subscription compared to mainboard issues.